Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Achilles Therapeutics (ACHL) Financial results for the third quarter of 2021.

09.11.2021

GAAP net loss is -$0.34.  

Cash and cash equivalents of the company are $281.9 million